Company Email Format

Adecto Pharmaceuticals

Biotechnology Research 75 Kneeland Street 6 employees

Employees: 6
Contacts: 2
Emails: 2
Phones: 1

adectopharma.com LinkedIn

Adecto Pharmaceuticals Overview

Headquarters: 75 Kneeland Street
Website: adectopharma.com
Industry: Biotechnology Research
Employees: 6
Founded: 2014
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Beverly

About Adecto Pharmaceuticals

Adecto is a pre-clinical stage, cancer therapeutics company, developing the first targeted therapy against ADAM8-expressing cancers and a companion diagnostic to identify patients who can benefit from it. ADAM8 is a critical driver of the growth and spread of many aggressive tumors, including those of the breast, stomach, colon, lungs, liver and pancreas, and is associated with poor patient survival. Adecto’s current focus is on breast cancer with a plan to expand to other oncology indications in the future. If you are interested in learning more, please visit us at www.adectopharma.com

Adecto Pharmaceuticals Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage
Phone contacts: 1; 33.3% coverage

Adecto Pharmaceuticals Org Chart

Sample employees and titles

Name	Title	Location	Contact
Mathilde Romagnoli	Biomarker Strategy Leader in Oncology at Servier	Paris, ÎLe-de-france, France	Email
Gail Sonenshein	Founder and President of Adecto Pharmaceuticals, Inc		View
Nora D. Mineva	CEO, Chief Scientist & Co-founder at Adecto Pharmaceuticals	Boston, Massachusetts, United States	Email Phone